Atrial Fibrillation
The MD Magazine Atrial Fibrillation condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Direct Oral Anticoagulants Gain Wide Acceptance, Especially for Patients with Atrial Fibrillation
New research suggests that the relative ease of using novel oral anticoagulants may be spurring more patients with atrial fibrillation to try anticoagulation and stick with it.
A new sub-analysis of data from the trial known as ROCKET-AF shows that rivaroxaban (Xarelto/Janssen) works as well in patients who have both non-valvular atrial fibrillation (AF) and diabetes as in AF patients without diabetes.
The US Food and Drug Administration has warned physicians that it may be dangerous to use a device known as the Lariat to close the left atrial appendage in patients with heart arrhythmias.
Study shows that diabetes duration (ie, how long they’ve had the disease) is linked with an increased risk of thromboembolism in patients with atrial fibrillation, but not with an increased risk of anticoagulation-related bleeding.
What factors must be considered to ensure optimal management of perioperative cardiac arrest in the cardiac surgery patient?

Most Popular

$vacMongoViewPlus$ $vAR$